Repligen: Q2 Earnings Snapshot
By AP News
Published - Jul 30, 2024, 12:52 PM ET
Last Updated - Jul 30, 2024, 12:52 PM EDT
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported second-quarter net income of $3.3 million.
On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 6 cents. Earnings, adjusted for non-recurring costs, were 33 cents per share.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for earnings of 33 cents per share.
The drug developer posted revenue of $154.1 million in the period, which missed Street forecasts. Seven analysts surveyed by Zacks expected $154.3 million.
